Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis

Andrea Iorio, Flavio De Angelis, Marco Di Girolamo, Marco Luigetti, Luca G Pradotto, Anna Mazzeo, Sabrina Frusconi, Filomena My, Dario Manfellotto, Maria Fuciarelli, Renato Polimanti

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Transthyretin (TTR) amyloidosis is a hereditary disease with a complex genotype-phenotype correlation. We conducted a literature survey to define the clinical landscape of TTR amyloidosis across populations worldwide. Then, we investigated whether the genetically determined TTR expression differs among human populations, contributing to the differences observed in patients. Polygenic scores for genetically determined TTR expression in 14 clinically relevant tissues were constructed using data from the GTEx (Genotype-Tissue Expression) project and tested in the samples from the 1,000 Genomes Project.

RESULTS: We observed differences among the ancestral groups and, to a lesser extent, among the investigated populations within the ancestry groups. Scandinavian populations differed in their genetically determined TTR expression of skeletal muscle tissue with respect to Southern Europeans (p = 6.79*10-6). This is in line with epidemiological data related to Swedish and Portuguese TTR Val30Met endemic areas. Familial amyloidotic cardiomyopathy (TTR deposits occur primarily in heart tissues) presents clinical variability among human populations, a finding that agrees with the among-ancestry diversity of genetically determined TTR expression in heart tissues (i.e., Atrial Appendage p = 4.55*10-28; Left Ventricle p = 6.54*10-35).

CONCLUSIONS: Genetically determined TTR expression varied across human populations. This might contribute to the genotype-phenotype correlation of TTR amyloidosis.

Original languageEnglish
Pages (from-to)254
JournalBMC Genomics
Volume18
Issue number1
DOIs
Publication statusPublished - Mar 23 2017

Fingerprint

Prealbumin
Population
Genetic Association Studies
Atrial Appendage
Inborn Genetic Diseases
Amyloidosis, Hereditary, Transthyretin-Related
Cardiomyopathies
Heart Ventricles
Skeletal Muscle
Genotype
Genome
Muscles

Keywords

  • Amyloidosis
  • Gene Expression Regulation
  • Genotype
  • Humans
  • Phenotype
  • Prealbumin
  • Journal Article
  • Research Support, Non-U.S. Gov't

Cite this

Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis. / Iorio, Andrea; De Angelis, Flavio; Di Girolamo, Marco; Luigetti, Marco; Pradotto, Luca G; Mazzeo, Anna; Frusconi, Sabrina; My, Filomena; Manfellotto, Dario; Fuciarelli, Maria; Polimanti, Renato.

In: BMC Genomics, Vol. 18, No. 1, 23.03.2017, p. 254.

Research output: Contribution to journalArticle

Iorio, A, De Angelis, F, Di Girolamo, M, Luigetti, M, Pradotto, LG, Mazzeo, A, Frusconi, S, My, F, Manfellotto, D, Fuciarelli, M & Polimanti, R 2017, 'Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis', BMC Genomics, vol. 18, no. 1, pp. 254. https://doi.org/10.1186/s12864-017-3646-1
Iorio, Andrea ; De Angelis, Flavio ; Di Girolamo, Marco ; Luigetti, Marco ; Pradotto, Luca G ; Mazzeo, Anna ; Frusconi, Sabrina ; My, Filomena ; Manfellotto, Dario ; Fuciarelli, Maria ; Polimanti, Renato. / Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis. In: BMC Genomics. 2017 ; Vol. 18, No. 1. pp. 254.
@article{0de3b43206834225910df3c18fd71c08,
title = "Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis",
abstract = "BACKGROUND: Transthyretin (TTR) amyloidosis is a hereditary disease with a complex genotype-phenotype correlation. We conducted a literature survey to define the clinical landscape of TTR amyloidosis across populations worldwide. Then, we investigated whether the genetically determined TTR expression differs among human populations, contributing to the differences observed in patients. Polygenic scores for genetically determined TTR expression in 14 clinically relevant tissues were constructed using data from the GTEx (Genotype-Tissue Expression) project and tested in the samples from the 1,000 Genomes Project.RESULTS: We observed differences among the ancestral groups and, to a lesser extent, among the investigated populations within the ancestry groups. Scandinavian populations differed in their genetically determined TTR expression of skeletal muscle tissue with respect to Southern Europeans (p = 6.79*10-6). This is in line with epidemiological data related to Swedish and Portuguese TTR Val30Met endemic areas. Familial amyloidotic cardiomyopathy (TTR deposits occur primarily in heart tissues) presents clinical variability among human populations, a finding that agrees with the among-ancestry diversity of genetically determined TTR expression in heart tissues (i.e., Atrial Appendage p = 4.55*10-28; Left Ventricle p = 6.54*10-35).CONCLUSIONS: Genetically determined TTR expression varied across human populations. This might contribute to the genotype-phenotype correlation of TTR amyloidosis.",
keywords = "Amyloidosis, Gene Expression Regulation, Genotype, Humans, Phenotype, Prealbumin, Journal Article, Research Support, Non-U.S. Gov't",
author = "Andrea Iorio and {De Angelis}, Flavio and {Di Girolamo}, Marco and Marco Luigetti and Pradotto, {Luca G} and Anna Mazzeo and Sabrina Frusconi and Filomena My and Dario Manfellotto and Maria Fuciarelli and Renato Polimanti",
year = "2017",
month = "3",
day = "23",
doi = "10.1186/s12864-017-3646-1",
language = "English",
volume = "18",
pages = "254",
journal = "BMC Genomics",
issn = "1471-2164",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis

AU - Iorio, Andrea

AU - De Angelis, Flavio

AU - Di Girolamo, Marco

AU - Luigetti, Marco

AU - Pradotto, Luca G

AU - Mazzeo, Anna

AU - Frusconi, Sabrina

AU - My, Filomena

AU - Manfellotto, Dario

AU - Fuciarelli, Maria

AU - Polimanti, Renato

PY - 2017/3/23

Y1 - 2017/3/23

N2 - BACKGROUND: Transthyretin (TTR) amyloidosis is a hereditary disease with a complex genotype-phenotype correlation. We conducted a literature survey to define the clinical landscape of TTR amyloidosis across populations worldwide. Then, we investigated whether the genetically determined TTR expression differs among human populations, contributing to the differences observed in patients. Polygenic scores for genetically determined TTR expression in 14 clinically relevant tissues were constructed using data from the GTEx (Genotype-Tissue Expression) project and tested in the samples from the 1,000 Genomes Project.RESULTS: We observed differences among the ancestral groups and, to a lesser extent, among the investigated populations within the ancestry groups. Scandinavian populations differed in their genetically determined TTR expression of skeletal muscle tissue with respect to Southern Europeans (p = 6.79*10-6). This is in line with epidemiological data related to Swedish and Portuguese TTR Val30Met endemic areas. Familial amyloidotic cardiomyopathy (TTR deposits occur primarily in heart tissues) presents clinical variability among human populations, a finding that agrees with the among-ancestry diversity of genetically determined TTR expression in heart tissues (i.e., Atrial Appendage p = 4.55*10-28; Left Ventricle p = 6.54*10-35).CONCLUSIONS: Genetically determined TTR expression varied across human populations. This might contribute to the genotype-phenotype correlation of TTR amyloidosis.

AB - BACKGROUND: Transthyretin (TTR) amyloidosis is a hereditary disease with a complex genotype-phenotype correlation. We conducted a literature survey to define the clinical landscape of TTR amyloidosis across populations worldwide. Then, we investigated whether the genetically determined TTR expression differs among human populations, contributing to the differences observed in patients. Polygenic scores for genetically determined TTR expression in 14 clinically relevant tissues were constructed using data from the GTEx (Genotype-Tissue Expression) project and tested in the samples from the 1,000 Genomes Project.RESULTS: We observed differences among the ancestral groups and, to a lesser extent, among the investigated populations within the ancestry groups. Scandinavian populations differed in their genetically determined TTR expression of skeletal muscle tissue with respect to Southern Europeans (p = 6.79*10-6). This is in line with epidemiological data related to Swedish and Portuguese TTR Val30Met endemic areas. Familial amyloidotic cardiomyopathy (TTR deposits occur primarily in heart tissues) presents clinical variability among human populations, a finding that agrees with the among-ancestry diversity of genetically determined TTR expression in heart tissues (i.e., Atrial Appendage p = 4.55*10-28; Left Ventricle p = 6.54*10-35).CONCLUSIONS: Genetically determined TTR expression varied across human populations. This might contribute to the genotype-phenotype correlation of TTR amyloidosis.

KW - Amyloidosis

KW - Gene Expression Regulation

KW - Genotype

KW - Humans

KW - Phenotype

KW - Prealbumin

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

U2 - 10.1186/s12864-017-3646-1

DO - 10.1186/s12864-017-3646-1

M3 - Article

C2 - 28335735

VL - 18

SP - 254

JO - BMC Genomics

JF - BMC Genomics

SN - 1471-2164

IS - 1

ER -